InvestorsHub Logo

SAMNOTSAMUEL

01/10/18 11:34 AM

#29739 RE: cvinvestor #29737

I suspect FDA started with a very hard line against delcath after 2013, but the preponderance of evidence is likely altering FDA view point. The positive news may well be that sooner or later, phase 3 will be a winner. Stability on stock price over next 6 months, ie trading between 5 and 10 cents, could mean the worst is behind